PACAP38 can also trigger migraine‐like attacks,134 cluster headache attacks,102, 135 and premonitory symptoms associated with migraine107 when infused intravenously into patients with migraine, cluster headache in bout or chronic cluster headache. This evidence concerns the gene ADCYAP1 and migraine disorder.